MARKET

ASRT

ASRT

Assertio Holdings Inc
NASDAQ
2.877
-0.073
-2.46%
Opening 15:22 11/28 EST
OPEN
2.910
PREV CLOSE
2.950
HIGH
2.960
LOW
2.835
VOLUME
347.25K
TURNOVER
626.28K
52 WEEK HIGH
4.440
52 WEEK LOW
1.260
MARKET CAP
138.96M
P/E (TTM)
5.37
1D
5D
1M
3M
1Y
5Y
TKC, AIU and NRBO are among pre market gainers
Seekingalpha · 11/09 13:33
BRIEF-Assertio Reports Third Quarter 2022 Financial Results
Reuters · 11/08 23:05
Assertio (ASRT) Q3 Earnings and Revenues Top Estimates
Assertio (ASRT) delivered earnings and revenue surprises of 14.29% and 9.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/08 22:45
UPDATE: Assertio Therapeutics Q3 Adj. EPS $0.22 Beats $0.07 Estimate
Benzinga · 11/08 22:05
Assertio Therapeutics Non-GAAP EPS of $0.22 beats by $0.11, revenue of $34.21M beats by $2.86M
Seekingalpha · 11/08 21:26
Assertio Raises FY22 GAAP Sales From $129M-$137M To $141M+; Adjusted Non-GAAP EBITDA From $73M-$79M To $86M+
Benzinga · 11/08 21:06
Assertio Therapeutics Q3 EPS $0.08 Beats $0.07 Estimate, Sales $34.21M Beat $31.33M Estimate
Benzinga · 11/08 21:02
-- Earnings Flash (ASRT) ASSERTIO HOLDINGS Posts Q3 EPS $0.22, vs. Street Est of $0.11
-- Earnings Flash (ASRT) ASSERTIO HOLDINGS Posts Q3 EPS $0.22, vs. Street Est of $0.11
MT Newswires · 11/08 16:23
More
About ASRT
Assertio Holdings, Inc. is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. The Company's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor (diclofenac potassium) Liquid filled capsules. The Company has other commercially available products, which include OXAYDO (oxycodone HCI, USP) tablets for oral use only. Assertio and Zyla are the registered trademarks of the Company. INDOCIN products are used for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.

Webull offers kinds of Assertio Holdings Inc stock information, including NASDAQ:ASRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASRT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ASRT stock methods without spending real money on the virtual paper trading platform.